KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Current Taxes (2016 - 2019)

Bristol Myers Squibb (BMY) has disclosed Current Taxes for 11 consecutive years, with $525.0 million as the latest value for Q1 2019.

  • On a quarterly basis, Current Taxes rose 77.36% to $525.0 million in Q1 2019 year-over-year; TTM through Mar 2019 was $525.0 million, a 77.36% increase, with the full-year FY2018 number at $398.0 million, up 72.29% from a year prior.
  • Current Taxes was $525.0 million for Q1 2019 at Bristol Myers Squibb, up from $398.0 million in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $572.0 million in Q4 2015 to a low of $98.0 million in Q2 2015.
  • A 5-year average of $295.9 million and a median of $291.0 million in 2017 define the central range for Current Taxes.
  • Peak YoY movement for Current Taxes: soared 118.32% in 2015, then crashed 73.43% in 2016.
  • Bristol Myers Squibb's Current Taxes stood at $572.0 million in 2015, then plummeted by 73.43% to $152.0 million in 2016, then skyrocketed by 51.97% to $231.0 million in 2017, then surged by 72.29% to $398.0 million in 2018, then soared by 31.91% to $525.0 million in 2019.
  • Per Business Quant, the three most recent readings for BMY's Current Taxes are $525.0 million (Q1 2019), $398.0 million (Q4 2018), and $355.0 million (Q3 2018).